Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum β-lactamase-producing Enterobacteriaceae

Antimicrobial Agents and Chemotherapy

Volumn 45, Issue 12, 2001, Pages 3548-3554

  Thomson, K S ^a   Moland, E S ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; MEROPENEM; PIPERACILLIN; TAZOBACTAM;

ANTIBACTERIAL ACTIVITY; ARTICLE; CITROBACTER; DRUG EFFECT; DRUG EFFICACY; ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA; NONHUMAN; PRIORITY JOURNAL; PROTEUS; SERRATIA; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CEPHALOSPORINS; CHROMOSOMES, BACTERIAL; DRUG RESISTANCE, MICROBIAL; ENTEROBACTERIACEAE; ENZYME INHIBITORS; ESCHERICHIA COLI; MICROBIAL SENSITIVITY TESTS; PENICILLANIC ACID; PENICILLINS; PIPERACILLIN;

EID: 0035189967     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.45.12.3548-3554.2001     Document Type: Article

References (47)

1. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli
2. Bacterial counts in cerebrospinal fluid of children with meningitis
3. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: Identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing β-lactamases in a single isolate
4. Development of test panel of β-lactamases expressed in a common Escherichia coli host background for evaluation of new β-lactam antibiotics
5. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial out break of multiresistant Klebsiella pneu-moniae
6. A functional classification scheme for β-lactamases and its correlation with molecular structure
7. Multiplicity of TEM-derived beta-lactamases from Kleb-siella pneumoniae strains isolated at the same hospital and relationships between the responsible plasmids
8. A 1998 survey of extended-spectrum β-lactamases in Enterobacteriaceae in France
9. TEM- and SHV-derived extended-spectrum β-lactamases: Relationship between selection, structure and function
10. Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and β-lactam-β-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase
11. Activities of β-lactam antibiotics against Escherichia coli strains producing extended-spectrum β-lactamases
12. More extended-spectrum β-lacta-mases
13. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: Hospital prevalence and susceptibility patterns
14. In vitro activities of various β-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalospo-rins
15. Treatment failure due to extended spectrum β-lactamase
16. Endocarditis
17. Different ratios of the piperacillin-tazobactam combination for treatment of experimental meningitis due to Klebsiella pneumoniae producing the TEM-3 extended-spectrum β-lactamase
18. β-lactamase-mediated resistance and opportunities for its control
19. Roles of β-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae
20. The use of analytical isoelectric focusing for detection and identification of β-lac-tamases
21. Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant
22. In vitro activity and beta-lactamase stability of FK-037, a parenteral cephalosporin
23. Effects of beta-lactamase from gram-negative organisms on cephalosporins and penicillins
24. Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs)
25. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: Implications for the clinical microbiology laboratory
26. Fatal infection due to extended-spectrum beta-lactamase-producing Escherichia coli: Implications for antibiotic choice for spontaneous bacterial peritonitis
27. Animal models of pneumonia for evaluation of antimicrobial therapy
28. Epidemiology of extended spectrum β-lactamases
29. Extended-spectrum beta-lactamases: How big is the problem?
30. In vivo efficacies of β-lactam-β-lactamase inhibitor combinations against a TEM-26-producing strain of Klebsiella pneumoniae
31. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center
32. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic-care facility
33. Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats
34. Cefepime: The next generation?
35. In vitro activity of fourth generation cephalosporins against enterobacteriaceae producing extended-spectrum beta-lactamases
36. Characterization of β-lactamases in situ on polyacrylamide gels
37. Extended-spectrum plasmid-mediated β-lactamases
38. In vitro testing: Correlations between bacterial suscep-tibility, body fluid levels and effectiveness of antibacterial therapy
39. The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics
40. Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum beta-lactamase-producing strain of Klebsiella pneumoniae
41. Novel plasmid-mediated β-lactamases in Enterobacteriaceae: Emerging problems for new β-lactam antibiotics
42. Version 2000: The new beta-lactamases of Gram-negative bacteria at the dawn of the new millennium
43. In vitro activity of cefpirome against selected clinical enterobacterial isolates with beta-lactamase-mediated resistance
44. Molecular epidemiology of an SHV-5 extended-spectrum beta-lactamase in Enterobacteriaceae isolated from infants in a neonatal intensive care unit